Group One Trading, L.P. Cidara Therapeutics, Inc. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$1.01 - $1.42 $24,827 - $34,906	-24,582 Reduced 78.72%	6,646 $7,000
Q1 2023 May 12, 2023	BUY	$0.75 - $1.98 $23,421 - $61,831	31,228 New	31,228 $39,000
Q2 2022 Aug 11, 2022	BUY	$0.43 - $0.91 $174 - $368	405 New	405 $0
Q4 2021 Feb 11, 2022	SELL	$1.18 - $2.18 $13,626 - $25,174	-11,548 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.48 - $2.35 $17,091 - $27,137	11,548 New	11,548 $26,000
Q2 2020 Aug 13, 2020	SELL	$2.39 - $4.0 $107 - $180	-45 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$1.74 - $4.26 $443 - $1,086	-255 Reduced 85.0%	45 $0
Q3 2019 Nov 12, 2019	SELL	$1.25 - $2.35 $125 - $235	-100 Reduced 25.0%	300 $1,000
Q3 2018 Nov 08, 2018	SELL	$3.7 - $5.25 $210 - $299	-57 Reduced 12.47%	400 $2,000
Q2 2018 Aug 14, 2018	SELL	$3.75 - $6.05 $2,073 - $3,345	-553 Reduced 54.75%	457 $2,000
Q1 2018 May 11, 2018	BUY	$4.0 - $8.15 $4,040 - $8,231	1,010 New	1,010 $4,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.